CancerCare

CancerCare is a leading national organization dedicated to providing free support services and financial assistance to anyone affected by cancer. 800-813-HOPE

[CancerCare @CancerCare]

Last year, @CancerCare provided 150,508 services to people diagnosed with cancer, caregivers and bereaved individuals. Our emotional, practical and financial support programs continued to offer help and hope to anyone affected by cancer.

Learn more at https://t.co/EGLy4PRLa1.

[CancerCare @CancerCare]

Support can look different for every head and neck cancer (HNC) and thyroid cancer (TC) patient, and caregivers are often a vital part of their journey. If you or someone you know is caring for someone with HNC or TC, here are resources that may help: https://t.co/V1SAy3t798

#ad

[FDA Drug Information @FDA_Drug_Info]

#FDA approves sacituzumab govitecan-hziy for two indications in adults with triple-negative breast cancer. https://t.co/Udx2EGxcZd

[FDA Oncology @FDAOncology]

#FDA approves a treatment for HR-positive, HER2-positive breast cancer. https://t.co/1bzMNxqTGq

[CancerCare @CancerCare]

FDA Fully Approves T-Cell Therapy for Advanced Synovial Sarcoma
https://t.co/1yCrD0Cjld

[CancerCare @CancerCare]

Mealtime has meaning – it can provide nourishment and moments of connection. But mealtime can feel different after a head and neck cancer (HNC) or thyroid cancer (TC) diagnosis. For stories and recipes from HNC and TC survivors, visit: https://t.co/MmHlra6SFV

#ad

[American Cancer Society Cancer Action Network @ACSCAN]

#ClinicalTrials can save lives from cancer. But not everyone can access them.

Congress has an opportunity to change this with a new bill. (1/2)

[Cancer Support Community @CancerSupportHQ]

Cancer Support Community is joined by other cancer advocacy organizations in strongly opposing provisions in the CMS interim final rule.

See our joint statement here: https://t.co/BIOZiCWy9C

[CancerNetwork® @CancerNetwrk]

The @US_FDA has approved capivasterib plus abiraterone and prednisone for patients with PTEN- deficient metastatic hormone-sensitive prostate cancer. #pcsm | @FDAOncology

https://t.co/bHTAe5u3m0

[Oncology Nursing News @OncNursingNews]

The FDA has approved belzutifan in combination with pembrolizumab for the adjuvant treatment of adult patients with clear cell renal cell carcinoma at high risk of recurrence: https://t.co/0DAYxLbcdo #RenalCellCarcinoma #FDAApproval #Belzutifan #Pembrolizumab #Welireg #Keytruda

[myTRIAList @myTRIAList]

Finding platinum-resistant #ovariancancer and #endometrialcancer clinical trials can feel overwhelming. Our trial finder supports people with cancer as they explore potential study options, such as the BEHOLD-1 study. Learn more: https://t.co/e8pOXO92aq
#CancerCare #ClinicalTrial

[Digital Health Awards @DHealthAwards]

BRONZE | CancerCare @CancerCare | myTRIAList (Web-based Digital Health: Website) #DHAS2026

[Genmab @Genmab]

During this edition of #AntibodyHour 🕙, hear from Vilmarie Rodriguez, VP of Patient Assistance & Community Engagement at @CancerCare who shares about Cancer Care’s work in developing programs for patients through counseling, support groups and patient advocacy. She shares how she has found purpose in helping others.

Her mission inspires us at Genmab as we move with the ambition to transform the lives of people living with cancer through innovative antibody medicines.

#PatientFirst

[CancerCare @CancerCare]

Health insurance barriers are disrupting the lives of people with cancer. CancerCare has been listening – and now it’s time to act.

Join us on June 17 for the Micro Insights, Macro Impact webinar.

Register here: https://t.co/i17HkOsuFY

#HealthcarePolicy #PatientAdvocacy

[myTRIAList @myTRIAList]

Neeta Somaiah, MD, gave her perspective on GIST clinical trials in myTRIAList’s INSIGHT study overview video. Keep up to date on the latest trial-overview videos in @CancerCare's myTRIAList Trial Finder here: https://t.co/wuEKqmZqlt

#GISTawareness #cancerresearch #oncologist #MD

[CancerCare @CancerCare]

FDA approves durvalumab in combination with Bacillus Calmette-Guerin for high-risk non-muscle invasive bladder cancer
https://t.co/zVoyEjnrAG

[CancerCare @CancerCare]

FDA approves pivekimab sunirine-pvzy for blastic plasmacytoid dendritic cell neoplasm, an ultra-rare hematologic malignancy
https://t.co/8PN6WBelbV

[FDA Oncology @FDAOncology]

#FDA approves a treatment for unresectable or metastatic triple-negative breast cancer. https://t.co/Pn8CY9cjo3

[CancerCare @CancerCare]

FDA Approves First Early-Stage Breast Cancer Indications for Trastuzumab Deruxtecan
https://t.co/eSh3EC8b7X

[FDA Oncology @FDAOncology]

#FDA approves a treatment for acute myeloid leukemia. https://t.co/JvB8z8wqgX

[FDA Oncology @FDAOncology]

#FDA grants accelerated approval to a treatment for relapsed or refractory mantle cell lymphoma. https://t.co/kiTjI1eJjN